BF Biosciences gains DRAP's approval for brownfield expansion

MG News | September 09, 2024 at 11:49 AM GMT+05:00

Add Mettisglobal as a Trusted Source on Google

0:00

September 09, 2024 (MLN): BF Biosciences Limited, a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ), has secured approval from the Drug Regulatory Authority of Pakistan (DRAP) for its brownfield expansion (Line II).

This expansion includes a pre-filled syringes line, a liquid and lyophilized line, and a product development section.

The commercial production from the pre-filled syringes line has commenced, whereas the liquid & lyophilized line is under internal validation and will start commercial production in the second quarter of FY 2024-25.

Additionally, BF Biosciences Limited has launched Sematide (Semaglutide) in a pre-filled syringe.

Sematide is the first Glucagon-Like Peptide 1 (GLP1) receptor agonist approved for local manufacture in Pakistan, offering a convenient solution for diabetes management.

The pre-filled syringe eliminates dosing errors and is easy to use by the patients.

Sematide is being manufactured at the new state-of-the-art European prefilled syringes line of BF Biosciences Limited.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	169,392.33 140.87M	0.85% 1421.67
ALLSHR	102,246.77 370.03M	0.62% 626.89
KSE30	50,468.10 50.48M	0.76% 379.72
KMI30	241,108.75 61.37M	0.48% 1151.64
KMIALLSHR	66,245.50 219.95M	0.50% 327.36
BKTi	46,992.31 14.07M	0.64% 300.00
OGTi	34,488.93 4.55M	0.11% 37.74

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	75,795.00	75,990.00 75,140.00	-370.00 -0.49%
BRENT CRUDE	108.22	108.48 107.62	-0.53 -0.49%
RICHARDS BAY COAL MONTHLY	130.00	0.00 0.00	2.75 2.16%
ROTTERDAM COAL MONTHLY	138.50	138.50 138.50	-0.80 -0.57%
USD RBD PALM OLEIN	1,228.00	1,228.00 1,228.00	0.00 0.00%
CRUDE OIL - WTI	105.16	105.63 104.69	-0.67 -0.63%
SUGAR #11 WORLD	17.98	18.30 17.88	-0.18 -0.99%